Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (301-310 of 348) with videos related to

Pageof 35
Sort By:
HIV Medicine|February 18, 2015
Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care systemE J Edelman, J P Tate, D A Fiellin, et al.
Drug and Alcohol Dependence|December 11, 2020
Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatmentEdouard Coupet, Gail D'Onofrio, Marek Chawarski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical PracticeMartin J Edelman, Daniel P Raymond, Dwight H Owen, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected PatientsDaniel F Weisberg, Kirsha S Gordon, Declan T Barry, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2018
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)Ajeet Gajra, Tyler J Zemla, Aminah Jatoi, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Pageof 35

Showing results (301-310 of 348) with videos related to

Sort By:
Pageof 35
HIV Medicine|February 18, 2015
Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care systemE J Edelman, J P Tate, D A Fiellin, et al.
Drug and Alcohol Dependence|December 11, 2020
Emergency department patients with untreated opioid use disorder: A comparison of those seeking versus not seeking referral to substance use treatmentEdouard Coupet, Gail D'Onofrio, Marek Chawarski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical PracticeMartin J Edelman, Daniel P Raymond, Dwight H Owen, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 27, 2015
Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected PatientsDaniel F Weisberg, Kirsha S Gordon, Declan T Barry, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2018
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)Ajeet Gajra, Tyler J Zemla, Aminah Jatoi, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Pageof 35